Eli Lilly profits were offset by spending on COVID-19 research
Expenses for the Indianapolis-based drugmaker rose due to investments in research to develop COVID-19 therapies. |!| Indianapolis
Expenses for the Indianapolis-based drugmaker rose due to investments in research to develop COVID-19 therapies. |!| Indianapolis